UNSPSC 51262500: Adrenergic blocking agent guanidines

This classification denotes adrenergic blocking agents made from a family of iminourea derivatives.

UNSPSC 51262500 Adrenergic blocking agent guanidines is a Class code that nominally covers pharmaceutical compounds, but recent state and local solicitations under this code show a mismatch between the abstract taxonomy name and actual procurement activity. The two recent opportunities posted are fundamentally unrelated to the code's stated scope: one solicits naloxone and drug deactivation systems (a public health emergency-response product), and the other is an exploratory Request for Information about direct-to-manufacturer prescription fulfillment programs. Neither opportunity involves adrenergic blocking agents or the pharmaceutical manufacturing and supply chain management the code name implies. The code shows little relevant recent activity aligned with its nominal definition.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The Texas Health and Human Services Commission issued RFI No. HHS0017013 on April 3, 2026, to gather vendor capabilities regarding a direct-to-manufacturer prescription program designed to improve fulfillment efficiency and cost management outside traditional pharmacy benefit manager and group purchasing organization channels. Because the recent-opportunities block contains no additional state and local solicitations under this code, the geographic spread and issuing-body mix cannot be reliably characterized beyond these two unrelated examples.